Low molecular weight heparin is associated with greater cytokine production in a stimulated whole blood model

被引:30
作者
Call, DR [1 ]
Remick, DG [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
来源
SHOCK | 1998年 / 10卷 / 03期
关键词
D O I
10.1097/00024382-199809000-00007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Anticoagulants can influence production of cytokines in whole blood, but the effects vary depending on the type of anticoagulant and the immunological stimulus. We examined this further by anticoagulating normal blood with either unfractionated (UF) heparin or low molecular weight heparin (Fragmin) and stimulating each sample with lipopolysaccharide, zymosan A, phytohemagglutinin, immune complexes, H2O2, or RPMI. After incubating 24 h, the combination of lipopolysaccharide and Fragmin induced significantly greater concentrations of interleukin 1 (IL)-1 beta (25 +/- 10 ng/mL; (x) over bar +/- standard error), IL-8 (21 +/- 6), and tumor necrosis factor (TNF)alpha (.48 +/- .24) compared with heparinized blood (p <.05), The combination of Fragmin and zymosan also induced significantly greater concentrations of IL-1 beta (97 +/- 24) and TNF alpha (2.9 +/- .8), but not IL-8 (2.0 +/- 15). Average levels of proinflammatory cytokines (IL-1 beta, IL-6, IL-8, and TNF alpha) were greater with Fragmin anticoagulation for 36 of 40 comparisons, and patterns were similar for 6 h and 24 h incubations. Statistical difference was established in 33% of these comparisons. A composite score of proinflammatory cytokines for Fragmin-anticoagulated blood was significantly greater than expected for UF heparinized blood (p <.0001) after 24 h, Expression of one anti-inflammatory cytokine (IL-10) was only slightly elevated for Fragmin anticoagulation. Proinflammatory cytokines are produced in greater quantities with Fragmin anticoagulation, which may be a disadvantage for ischemic conditions (e.g,, cardiac surgery) but advantageous for long-term treatment of thrombosis.
引用
收藏
页码:192 / 197
页数:6
相关论文
共 31 条
  • [1] PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES
    AARDEN, LA
    DEGROOT, ER
    SCHAAP, OL
    LANSDORP, PM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) : 1411 - 1416
  • [2] HEPARIN DEGRADATION IN THE ENDOTHELIAL-CELLS
    BARZU, T
    VANRIJN, JLML
    PETITOU, M
    TOBELEM, G
    CAEN, JP
    [J]. THROMBOSIS RESEARCH, 1987, 47 (05) : 601 - 609
  • [3] Circulating cytokines and granulocyte-derived enzymes during complex heart surgery - A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits
    Borowiec, JW
    Hagman, L
    Totterman, TH
    Pekna, M
    Venge, P
    Thelin, S
    [J]. SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 29 (04): : 167 - 174
  • [4] COCCHERI S, 1990, HAEMOSTASIS, V20, P74
  • [5] TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 SERUM LEVELS DURING SEVERE SEPSIS IN HUMANS
    DAMAS, P
    REUTER, A
    GYSEN, P
    DEMONTY, J
    LAMY, M
    FRANCHIMONT, P
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (10) : 975 - 978
  • [6] HEPARIN INHIBITS THE ANTIPARASITIC AND IMMUNE MODULATORY EFFECTS OF HUMAN RECOMBINANT INTERFERON-GAMMA
    DAUBENER, W
    NOCKEMANN, S
    GUTSCHE, M
    HADDING, U
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (03) : 688 - 692
  • [7] SANDWICH ELISA FOR DETECTION OF PICOGRAM QUANTITIES OF INTERLEUKIN-8
    DEFORGE, LE
    REMICK, DG
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 1991, 20 (01) : 89 - 97
  • [8] ElHabbal MH, 1995, CARDIOVASC RES, V30, P676, DOI 10.1016/0008-6363(95)00069-0
  • [9] Engstad CS, 1997, THROMB HAEMOSTASIS, V77, P690
  • [10] A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES
    ESPEVIK, T
    NISSENMEYER, J
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) : 99 - 105